WHAT WE DO:
OUR STRATEGIC APPROACH
Wekayah Pharma strategically positions itself in the generic pharmaceutical trading and manufacturing industry through a multifaceted approach. Our goal is to produce, market, and distribute medicines while obtaining regulatory approval.
Contract
Manufacturing Approach
In this strategic framework, Wekayah Pharma will spearhead the development of unique pharmaceutical offerings, underscoring our unwavering commitment to innovation. These distinct products, bearing the Wekayah Pharma brand, will encompass various healthcare sectors, including mental health, lipid regulation, diabetes management, respiratory health, pain relief, antibacterial treatments, neurological disorders, hypertension management, ulcer treatment, anticoagulants, and nutraceuticals. Through a blend of contract manufacturing and in-licensing strategies, we guarantee the production of top-tier pharmaceuticals while solidifying our brand footprint across a diverse spectrum of therapeutic domains.
Exclusive Agency for Fast-Moving OTC/GSL Products
Wekayah Pharma is positioned to secure the exclusive agency rights for unique fast-moving Over the Counter (OTC) and General Sales List (GSL) products, overseeing their marketing and distribution across the Gulf Cooperation Council (GCC) region. By assuming sole representation of these products, we aim to streamline their market presence, ensuring widespread visibility and availability. This strategic move is designed to establish a strong foothold in the GCC market and capitalize on the demand for OTC and GSL offerings.
This comprehensive strategy enables Wekayah Pharma to operate effectively in generic pharmaceutical manufacturing and trading. By focusing on contract manufacturing and exclusive agency for OTC/GSL products, we expand our product range and position ourselves as a leading healthcare solutions provider in the GCC market, aligning with our mission to transform healthcare through innovation and accessibility.
Exclusive Agency for Fast-Moving OTC/GSL Products
This diversified business strategy allows Wekayah Pharma to operate efficiently in both generic pharmaceutical manufacturing and trading. The emphasis on contract manufacturing for unique pharmaceuticals and the exclusive agency for fast-moving OTC/GSL products not only broadens our product portfolio but also positions us as a comprehensive healthcare solutions provider in the GCC market. This strategic approach aligns with our overarching mission to revolutionize healthcare and underscores our commitment to innovation, excellence, and accessibility in pharmaceuticals.
Exclusive Agency for Fast-Moving OTC/GSL Products
Wekayah Pharma is poised to take the exclusive agency of unique fast-moving Over the Counter (OTC) and General Sales List (GSL) products. In this model, we will assume responsibility for both marketing and distribution of these fast-moving products throughout the Gulf Cooperation Council (GCC) region. By exclusively representing these products, we aim to streamline the marketing and distribution process, ensuring optimal visibility and availability in the market. This approach serves as a strategic move to establish a robust presence in the GCC region while capitalizing on the demand for OTC and GSL products.
Partner with Wekayah
we are seeking strategic partnerships with like-minded organizations that share our vision of enhancing healthcare outcomes.
We believe that a partnership with your esteemed company could be mutually beneficial, allowing us to leverage our combined strengths
to make a greater impact in the healthcare industry.
Join us in our mission to transform healthcare and improve lives. Let’s explore the possibilities together!
For more information, please fill the (become a partner form).